Standards & Compliance Library

CMS conditions reimbursement for remote patient monitoring on the documented involvement of a physician or qualified healthcare professional (QHP). Association guidance treats practitioner involvement as the first element a program must evidence, because every downstream billing event depends on it. This article sets out the documentation the Association expects a member to maintain: the ordering practitioner's identity and NPI, the clinical rationale connecting monitoring to the patient's condition, the date the order was placed, and the established relationship with the patient. Members should retain the order itself, not merely a reference to it. Where monitoring is initiated at hospital discharge or through a standing program, the guidance addresses how to document the initial order and any re-authorization. The article closes with a self-audit sequence: sample ten claims per quarter, trace each to its order, and record the reviewer's findings.

The 30-day period is the unit of billing for device supply and treatment-management services under CPT 99454, and misaligned periods are the most common billing error the Association sees in remote monitoring programs. This article walks through correct period construction: the period starts when the device is supplied and the patient begins transmission, not when the enrollment call concludes. It covers partial-month situations at program start and end, how to handle a patient who stops transmitting mid-period, and why a member should never bill a period in which fewer than sixteen days of patient-generated data were transmitted. The guidance includes a record-keeping specification for device-readiness attestations and a worked example comparing correct and incorrect claim periods for a ninety-day monitoring episode.

CPT 99457 and 99458 reimburse treatment-management services built on interactive communication with the patient or caregiver during the monitoring period. This article defines what the Association considers acceptable documentation of engagement time: contemporaneous entries identifying the team member who rendered the service, the date and duration, the modality, and a summary of the clinical content of the interaction. Bulk time entries without individual records do not meet the standard. The article distinguishes physician or QHP time from clinical-staff time under general supervision and explains how the 20-minute increments of 99458 must be evidenced. It closes with two model documentation formats members may adopt directly: a per-interaction log and a weekly structured review note.

A standards body holds its members to the claims they publish. This article sets the Association's substantiation rule: before a member states a measurable result in any public channel — website, brochure, sales deck, or trade interview — it must hold a substantiation file recording the source of the figure, the population measured, the measurement period, and the method. Marketing language that implies clinical outcomes the program has not measured is a reputation violation under the membership code. The article gives worked examples distinguishing supportable claims ("median time-to-first-review of 26 hours across 412 patients in 2025, per internal QA records") from unsupported ones ("we reduce readmissions"), and describes how the Office of Admissions weighs unsubstantiated claims during verification review.

The Association's verified badge is issued to a specific organization, for a specific scope, after admission review. It is not transferable. This article defines permitted badge placement: the member's website, verified directory listing, and practice materials identifying the member organization itself. It defines prohibited placement: badge display on products, partner organizations, or new service lines that have not completed their own review; presentation of the badge as a CMS or OIG endorsement, which the Association never conveys; and use of Association seals in advertising that suggests certification of individual clinicians. The article explains the annual review's badge implications and the revocation procedure, including the ten-business-day window a member has to correct a scope-of-use issue before revocation is published.

Association standards treat a remote monitoring engagement as a defined set of deliverables, owed to both the referring provider and the patient. This article specifies the four the Association requires members to document at enrollment: the monitoring plan stating what will be measured and at what frequency; the equipment package with setup and troubleshooting support; the clinical review commitment stating who reviews transmitted data and on what schedule; and the communication protocol defining when and how the member contacts the patient and the referring provider. Members must record the deliverables in a written enrollment summary provided to the patient. The article discusses handling deviations — a patient who cannot transmit daily, a device that fails — and the documentation each deviation requires.

The Association's fourth pillar takes its name and its force from the federal honest-services fraud statute, 18 U.S.C. § 1346, which protects patients and payers from schemes to deprive them of the intangible right of honest services. A monitoring program deprives patients of honest services when it conceals arrangements that could influence clinical recommendations — device-supply relationships with affiliates, referral payments, or billing practices the patient's plan would not recognize. This article sets the Association's disclosure standard: members identify to the referring provider, in writing, any financial interest the member holds in the devices or services it recommends, and members do not select monitoring equipment on terms that place the member's revenue ahead of the patient's clinical needs. The article relates the standard to the OIG's exclusion authorities and the anti-kickback statute, and describes the attestation each member files at annual review.

Patients consent to remote monitoring as a service, and the consent conversation is a deliverable in its own right. This article defines the elements of an adequate consent record: the devices and data categories being collected, how often data transmits, who reviews it and when, the clinical limits of monitoring — including that monitoring does not replace emergency care — the patient's financial responsibility under their plan, and how the patient may end participation. Members must present consent information in plain language and record the date and method of consent. The article addresses special cases: monitoring through a caregiver, patients with limited English proficiency, and consent renewal after a program change alters what was originally disclosed.